Ciprofloxacin

Fluoroquinolone Antibiotic — Antibiotics

• Drug Class: Fluoroquinolone Antibiotic
• Category: Antibiotics
• Type: Small Molecule
• SMILES: O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O

What is Ciprofloxacin?

Ciprofloxacin is a widely prescribed synthetic antibiotic belonging to the fluoroquinolone class. It is a broad-spectrum agent effective against a variety of Gram-positive and Gram-negative bacteria. Commonly known by its brand name Cipro, it is used to treat numerous types of bacterial infections, ranging from common urinary tract infections to more severe conditions like anthrax. Its efficacy stems from its ability to interfere with essential bacterial enzymes, thereby halting bacterial growth and replication. Ciprofloxacin is available in various formulations, including oral tablets, intravenous solutions, and ophthalmic preparations, making it a versatile tool in combating bacterial pathogens.

Mechanism of Action

The potent antibacterial activity of ciprofloxacin is attributed to its ability to inhibit two crucial bacterial enzymes: DNA gyrase (also known as topoisomerase II) and topoisomerase IV. These enzymes are essential for bacterial DNA replication, transcription, repair, and recombination.

DNA Gyrase Inhibition

In Gram-negative bacteria, DNA gyrase is the primary target. DNA gyrase is responsible for introducing negative supercoils into bacterial DNA, a process vital for relieving torsional stress during DNA replication and transcription. By binding to the DNA gyrase complex, ciprofloxacin prevents the enzyme from performing its function, leading to the accumulation of double-strand breaks in the bacterial DNA. This ultimately triggers a cell death pathway.

Topoisomerase IV Inhibition

In many Gram-positive bacteria, topoisomerase IV is the preferred target. This enzyme plays a critical role in decatenating, or separating, newly replicated bacterial chromosomes. Inhibition of topoisomerase IV by ciprofloxacin prevents the proper segregation of daughter DNA molecules, leading to cell division arrest and bacterial death.

The molecular structure of ciprofloxacin, particularly the presence of a fluorine atom at the 6-position and a piperazine ring at the 7-position of the quinolone core, is crucial for its potent activity against both DNA gyrase and topoisomerase IV. This dual mechanism of action contributes to its broad spectrum of activity and its effectiveness against many resistant bacterial strains.

Clinical Uses & Indications

Ciprofloxacin is indicated for the treatment of a wide array of bacterial infections caused by susceptible microorganisms. Its broad spectrum of activity makes it a valuable agent for both community-acquired and hospital-acquired infections. FDA-approved indications include:

• Urinary Tract Infections (UTIs): Ciprofloxacin is highly effective against common uropathogens like Escherichia coli and Klebsiella pneumoniae, making it a first-line treatment for complicated and uncomplicated UTIs.
• Respiratory Tract Infections: It is used for acute sinusitis, acute exacerbations of chronic bronchitis, and community-acquired pneumonia, particularly when caused by susceptible pathogens like Haemophilus influenzae and Streptococcus pneumoniae.
• Skin and Skin Structure Infections: Effective for treating infections caused by susceptible bacteria, including cellulitis, erysipelas, and infected wounds.
• Bone and Joint Infections: Used in the management of osteomyelitis and septic arthritis when caused by susceptible organisms.
• Intra-abdominal Infections: Often used in combination with other antibiotics for the treatment of complicated intra-abdominal infections, such as peritonitis and abscesses.
• Infectious Diarrhea: Ciprofloxacin is indicated for infectious diarrhea caused by susceptible strains of Shigella, Salmonella, and E. coli.
• Typhoid Fever: It is an effective treatment for typhoid fever caused by Salmonella Typhi.
• Anthrax: Ciprofloxacin is a critical treatment for inhalational anthrax (post-exposure prophylaxis) and cutaneous anthrax.
• Plague: Used for the treatment of plague caused by Yersinia pestis.
• Prostatitis: Effective for bacterial prostatitis.
• Gonorrhea: While resistance is increasing, it may still be used in certain cases of uncomplicated gonorrhea.

It's important to note that ciprofloxacin should only be used when alternative antibiotics are not suitable due to potential risks and the development of antibiotic resistance.

Dosage & Administration

The dosage and administration of ciprofloxacin vary depending on the type and severity of the infection, the patient's age, renal function, and the chosen dosage form. It is crucial to complete the full course of treatment as prescribed by a healthcare professional, even if symptoms improve.

Common Dosage Forms and Routes:

• Oral Tablets: Available in strengths of 250 mg, 500 mg, and 750 mg. Tablets are typically taken every 12 hours. They should be swallowed whole with plenty of water and can be taken with or without food. However, taking them with food may reduce gastrointestinal upset. Avoid taking with dairy products or calcium-fortified juices, as calcium can interfere with absorption.
• Intravenous (IV) Solution: Available in concentrations such as 200 mg/100 mL and 400 mg/200 mL. IV administration is usually reserved for severe infections or when oral administration is not possible. The infusion rate should be carefully controlled to avoid adverse reactions.
• Ophthalmic Solution: Used for bacterial conjunctivitis and corneal ulcers. Typically administered as drops into the affected eye(s) multiple times a day.
• Otic Solution: Used for acute otitis externa (swimmer's ear). Administered as drops into the ear canal.

Dosage Adjustments:

Patients with impaired renal function typically require dosage adjustments to prevent the accumulation of the drug and potential toxicity. Healthcare providers will determine the appropriate dosage based on the patient's creatinine clearance.

Side Effects & Safety

While ciprofloxacin is generally well-tolerated, it can cause a range of side effects, from mild to severe. Awareness of these potential risks is crucial for safe use.

Common Side Effects:

• Nausea
• Diarrhea
• Vomiting
• Abdominal pain
• Headache
• Dizziness
• Rash

Serious Side Effects:

These require immediate medical attention:

• Tendonitis and Tendon Rupture: Fluoroquinolones, including ciprofloxacin, carry a risk of tendonitis and tendon rupture, particularly affecting the Achilles tendon. This risk is higher in older adults, those taking corticosteroids, and patients with kidney, heart, or lung transplants.
• Peripheral Neuropathy: Ciprofloxacin can cause nerve damage, leading to symptoms such as pain, burning, tingling, numbness, and weakness in the extremities. This can be irreversible.
• Central Nervous System (CNS) Effects: May include dizziness, lightheadedness, confusion, hallucinations, paranoia, and, rarely, seizures. Patients with known CNS disorders should use ciprofloxacin with caution.
• QT Interval Prolongation: Ciprofloxacin can prolong the QT interval on an electrocardiogram, increasing the risk of potentially fatal arrhythmias like Torsades de Pointes. Caution is advised in patients with risk factors for QT prolongation.
• Clostridioides difficile-Associated Diarrhea (CDAD): Like most antibiotics, ciprofloxacin can disrupt the normal gut flora, leading to overgrowth of C. difficile and potentially severe diarrhea.
• Photosensitivity: Increased sensitivity to sunlight, leading to exaggerated sunburn reactions. Patients should avoid excessive sun exposure and use protective measures.
• Hypoglycemia and Hyperglycemia: Fluctuations in blood sugar levels can occur, particularly in diabetic patients.
• Aortic Aneurysm and Dissection: Post-marketing surveillance has indicated an increased risk of aortic aneurysm and dissection, particularly in older patients.

Contraindications:

Ciprofloxacin is contraindicated in patients with:

• A known hypersensitivity to ciprofloxacin, other quinolones, or any component of the formulation.
• A history of tendon disorders related to fluoroquinolone administration.
• Children and adolescents (under 18 years) for certain indications, due to the risk of arthropathy (joint problems).

Black Box Warnings: Ciprofloxacin carries boxed warnings regarding serious adverse reactions, including tendon rupture, peripheral neuropathy, CNS effects, and exacerbation of myasthenia gravis. Patients should be counselled on these risks.

Drug Interactions

Ciprofloxacin can interact with several medications, potentially altering their efficacy or increasing the risk of adverse events. Careful consideration of these interactions is essential:

• Antacids, Sucralfate, Metal Cations: Antacids containing magnesium or aluminum, sucralfate, and products containing iron, zinc, or calcium (including dairy products and calcium-fortified juices) can significantly reduce the oral absorption of ciprofloxacin. These should be taken at least 2 hours before or 6 hours after ciprofloxacin.
• Theophylline: Ciprofloxacin can inhibit the metabolism of theophylline, leading to increased serum concentrations and potential theophylline toxicity (e.g., nausea, vomiting, seizures, cardiac arrhythmias).
• Warfarin: Ciprofloxacin may potentiate the anticoagulant effect of warfarin, increasing the risk of bleeding. Close monitoring of prothrombin time/INR is recommended.
• Caffeine: Ciprofloxacin can inhibit the metabolism of caffeine, leading to increased caffeine levels and potential side effects like nervousness, insomnia, and heart palpitations.
• Nonsteroidal Anti-inflammatory Drugs (NSAIDs): Concomitant use of NSAIDs with fluoroquinolones may increase the risk of CNS stimulation and seizures.
• Corticosteroids: Concurrent use increases the risk of tendonitis and tendon rupture.
• Oral Hypoglycemic Agents: Ciprofloxacin may enhance the effect of oral hypoglycemic agents, leading to hypoglycemia.
• Methotrexate: Ciprofloxacin may inhibit the renal clearance of methotrexate, leading to increased serum levels and potential methotrexate toxicity.
• QTc-Prolonging Drugs: Concomitant use with other drugs known to prolong the QT interval (e.g., antiarrhythmics, some antipsychotics, macrolide antibiotics) may increase the risk of ventricular arrhythmias.

Molecular Properties

Understanding the molecular characteristics of ciprofloxacin is key to comprehending its behavior and interactions within biological systems.

Chemical Name: 1-cyclopropyl-6-fluoro-4-oxo-7-(piperazin-1-yl)-1,4-dihydroquinoline-3-carboxylic acid

Molecular Formula: C₁₇H₁₈FN₃O₃

Molecular Weight: 331.34 g/mol

Structure Description: Ciprofloxacin is a synthetic chemotherapeutic agent that belongs to the fluoroquinolone class. Its core structure is a quinolone ring system. Key functional groups contributing to its activity include:

• A cyclopropyl group attached to the nitrogen at position 1.
• A fluorine atom at position 6, which enhances antibacterial activity and tissue penetration.
• A piperazine ring at position 7, which broadens the spectrum of activity, particularly against Gram-negative bacteria.
• A carboxylic acid group at position 3 and a ketone group at position 4, which are essential for binding to bacterial DNA gyrase and topoisomerase IV.

SMILES notation: O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O

This SMILES string provides a linear representation of the molecule's structure, detailing the connectivity of its atoms and functional groups. The presence of fluorine and the piperazine moiety are significant contributors to its potent and broad-spectrum antibacterial properties.

Analyze Ciprofloxacin with MolForge

Ciprofloxacin exemplifies the intricate relationship between molecular structure and pharmacological activity. Its journey from discovery to widespread clinical use highlights the power of medicinal chemistry and drug development. Understanding its mechanism, potential side effects, and interactions is paramount for healthcare professionals and researchers alike.

MolForge's AI-powered platform offers advanced tools to delve deeper into the properties of molecules like ciprofloxacin. Explore its structure-activity relationships, predict its pharmacokinetic profiles, identify potential off-target effects, and discover novel analogs. By leveraging cutting-edge AI, MolForge can accelerate your research and development efforts. Discover the future of molecular discovery today by visiting our dashboard and exploring the capabilities of MolForge.